Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 319.5 Million USD | -43.66% |
| 2022 | 214.6 Million USD | 30.14% |
| 2021 | 164.9 Million USD | 13.18% |
| 2020 | 145.7 Million USD | -11.0% |
| 2019 | 163.7 Million USD | 4.11% |
| 2018 | 157.23 Million USD | 0.55% |
| 2017 | 156.36 Million USD | 26.45% |
| 2016 | 123.65 Million USD | 10.58% |
| 2015 | 111.82 Million USD | 112.36% |
| 2014 | 52.66 Million USD | 19.18% |
| 2013 | 44.18 Million USD | 11.62% |
| 2012 | 39.58 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 40.3 Million USD | 21.39% |
| 2024 Q1 | 33.2 Million USD | 58.85% |
| 2023 Q2 | 54.4 Million USD | -15.79% |
| 2023 Q1 | 64.6 Million USD | 11.96% |
| 2023 FY | 120.9 Million USD | -43.66% |
| 2023 Q4 | 20.9 Million USD | -80.86% |
| 2023 Q3 | 109.2 Million USD | 100.74% |
| 2022 Q3 | 47.2 Million USD | -8.17% |
| 2022 Q2 | 51.4 Million USD | -7.72% |
| 2022 Q4 | 57.7 Million USD | 22.25% |
| 2022 FY | 214.6 Million USD | 30.14% |
| 2022 Q1 | 55.7 Million USD | 74.06% |
| 2021 FY | 164.9 Million USD | 13.18% |
| 2021 Q1 | 37.4 Million USD | 3.03% |
| 2021 Q3 | 50.2 Million USD | 19.52% |
| 2021 Q4 | 32 Million USD | -36.25% |
| 2021 Q2 | 42 Million USD | 12.3% |
| 2020 Q3 | 59.2 Million USD | 996.3% |
| 2020 FY | 145.7 Million USD | -11.0% |
| 2020 Q1 | 43.1 Million USD | 0.47% |
| 2020 Q4 | 36.3 Million USD | -38.68% |
| 2020 Q2 | 5.4 Million USD | -87.47% |
| 2019 Q1 | 40.5 Million USD | -2.93% |
| 2019 Q4 | 42.9 Million USD | 12.01% |
| 2019 Q3 | 38.3 Million USD | -8.81% |
| 2019 Q2 | 42 Million USD | 3.7% |
| 2019 FY | 163.7 Million USD | 4.11% |
| 2018 Q4 | 41.72 Million USD | -10.79% |
| 2018 Q1 | 45.67 Million USD | -6.12% |
| 2018 Q2 | 48.84 Million USD | 6.94% |
| 2018 Q3 | 46.77 Million USD | -4.25% |
| 2018 FY | 157.23 Million USD | 0.55% |
| 2017 Q3 | 308 Million USD | 762.77% |
| 2017 FY | 156.36 Million USD | 26.45% |
| 2017 Q4 | 48.65 Million USD | -84.2% |
| 2017 Q2 | 35.69 Million USD | 10.93% |
| 2017 Q1 | 32.18 Million USD | -11.03% |
| 2016 FY | 123.65 Million USD | 10.58% |
| 2016 Q3 | 33.57 Million USD | 18.61% |
| 2016 Q4 | 36.17 Million USD | 7.73% |
| 2016 Q2 | 28.3 Million USD | 10.57% |
| 2016 Q1 | 25.6 Million USD | -27.98% |
| 2015 Q2 | 25.37 Million USD | -0.49% |
| 2015 Q1 | 25.49 Million USD | 29.73% |
| 2015 FY | 111.82 Million USD | 112.36% |
| 2015 Q3 | 25.41 Million USD | 0.17% |
| 2015 Q4 | 35.54 Million USD | 39.87% |
| 2014 Q3 | 10.95 Million USD | 16.1% |
| 2014 Q1 | 11.73 Million USD | 0.0% |
| 2014 Q2 | 9.43 Million USD | -19.61% |
| 2014 FY | 52.66 Million USD | 19.18% |
| 2014 Q4 | 19.65 Million USD | 79.41% |
| 2013 FY | 44.18 Million USD | 11.62% |
| 2012 FY | 39.58 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -81.521% |
| Addus HomeCare Corporation | 248.92 Million USD | -28.354% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -170.026% |
| Amedisys, Inc. | 834.47 Million USD | 61.713% |
| Astrana Health, Inc. | 112.59 Million USD | -183.755% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 45.604% |
| IMAC Holdings, Inc. | 5.02 Million USD | -6255.52% |
| biote Corp. | 98.82 Million USD | -223.295% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -807.531% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 5.389% |
| COMPASS Pathways plc | 136.91 Million USD | -133.35% |
| DocGo Inc. | 180.32 Million USD | -77.178% |
| The Ensign Group, Inc. | 335.39 Million USD | 4.738% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -68.965% |
| InnovAge Holding Corp. | 558.25 Million USD | 42.768% |
| The Joint Corp. | 109.22 Million USD | -192.521% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 34.959% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -1651.441% |
| ModivCare Inc. | 586.89 Million USD | 45.561% |
| NewGenIvf Group Limited | 1.63 Million USD | -19387.138% |
| Option Care Health, Inc. | 666.62 Million USD | 52.072% |
| P3 Health Partners Inc. | 199.56 Million USD | -60.098% |
| P3 Health Partners Inc. | 199.56 Million USD | -60.098% |
| The Pennant Group, Inc. | 88.99 Million USD | -259.009% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -7331.098% |
| Talkspace, Inc. | 97.58 Million USD | -227.393% |
| Talkspace, Inc. | 97.58 Million USD | -227.393% |
| The Oncology Institute, Inc. | 136.59 Million USD | -133.91% |
| The Oncology Institute, Inc. | 136.59 Million USD | -133.91% |